Stay updated with breaking news from Life Sciences Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Azenta, Inc. (NASDAQ:AZTA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the four research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […]
Jennison Associates LLC boosted its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 0.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 216,796 shares of the company’s stock after acquiring an additional 1,092 shares during the quarter. Jennison Associates LLC owned about 0.31% […]
Ceredex Value Advisors LLC lowered its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 26.2% during the 1st quarter, HoldingsChannel reports. The firm owned 1,061,700 shares of the company’s stock after selling 377,750 shares during the period. Ceredex Value Advisors LLC’s holdings in Azenta were worth $47,373,000 as of its most recent filing with […]
Olympus (OTCMKTS:OLYMY – Free Report) and Azenta (NASDAQ:AZTA – Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Valuation & Earnings This table compares Olympus and Azenta’s revenue, earnings per […]
Moody National Bank Trust Division grew its position in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 34.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,470 shares of the company’s stock after buying an additional 8,036 shares during the […]